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Gene that is introduced into the cell from an external source is called transgene. A fertile 
animal that carries an introduced gene (s) in its germ line is called transgenic animal. The 
introduction of gene (s) into animl cells that leads to the transmission of the input 
transgene to successive generation is called transgenesis. This article discuses and 
summarizes important work in the literature regarding the gene transfer technologies 
leading to transgenic animals. The main techniques focused in this article are DNA 
transfer to anmals by microinjection, biolistics and electroporation. Much stress has been 
given to embryonic stem cell technology, sperm-mediated gene transfer, intracytoplasmic 
sperm injection (ICSI), liposome/DNA delivery method, gene transfer by retrovirus and 
nuclear transfer method.  Models for transgenic animals were also focussed. The author 
also reviewed the transgenic animals as bioreactors, pharmaceutical proteins derived from 
these animals and transgenic expression of immunoglobulin. This article will be a 





Gene is a segment of DNA containing biological 
information and hence coding an RNA and/or 
polypeptide molecule. A transgene is a gene that is 
introduced into a cell or animal from an external 
source. Recombinant DNA technology has brought 
about complete revolution in the way living 
organisms are exploited. By transferring new DNA 
sequences into animals or by removing or altering 
DNA sequences in the endogeneous genome, 
completely new strains or varieties can be created to 
form specific tasks. An organism whose genetic 
composition has been altered by the addition of 
exogenous DNA is said to be transgenic. 
Transgenic animals are produced by introduction 
of „foreign‟ deoxyribonucleic acid (DNA) into 
preimplantation embryos. The foreign DNA is 
inserted into the genetic material and may be 
expressed in tissues of the resulting individual. The 
author reviewed a number of gene transfer 
technologies like DNA transfer by microinjection, 
biolistics and electroporation. The author gave much 
emphasis to embryonic stem cell technology, sperm-
mediated gene transfer, intracytoplasmic sperm 
injection (ICSI), liposome/DNA delivery method, 
gene transfer by retrovirus and nuclear transfer 
method. He also reviewed the different models for 
transgenic animals. In this article various applications 
of transgenic animals were discussed. The author also 
reviewed transgenic animals as bioreactors and 
studied pharmaceutical proteins derived from these 
animals and also transgenic expression of 
immunoglobulin.  
These technique are of great importance to many 
aspects of biomedical sciences including gene 
regulation, the immune system, cancer research, 
developmental biology, biomedicine and agriculture. 
The production of transgenic animals is one of a 
number of new and developing technologies that will 
have a profound impact on the genetic improvement 
of livestock. The reason why transgenic animal is 
made is listed in the Table 1. 
 
Table 1. Reasons for producing transgenic animals 
 
S. No Reasons  
1. Gain new knowledge. 
2. Decipher the genetic code. 
3. Study the genetic control of physiological 
systems. 
4. Build genetic disease models. 
5. Improve animal production traits. 
6. Produce new animal products. 
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This article will be beneficial for those readers 
who are going to start their career in the field of gene 
transfer technologies in animals leading to transgenic. 
 
2. Methods for genetic modification 
 
It was Gorden and Ruddle who in 1981 coined 
the term „transgenic‟ [1] to explain an animal in which 
an exogenous gene was introduced into its genome. 
In the late 1980s, the term transgenic was extended to 
gene-targeting experimentation and the production of 
chimeric or „knockout‟ mice in which a gene (or 
genes) has been selectively removed from the host 
genome [2]-[3]. Today, a transgenic animal can be 
defined as one having any specific, targeted genetic 
modification. There are a number of methodologies 
which can be utilized for the production of transgenic 
animals and are listed in the Table 2. 
 
Table 2. Methodologies that can be used for the production of 
transgenic animals. 
 
S. No Technologies that produce transgenic 
animals 
1. DNA microinjection. 
2. DNA transfer by retroviruses. 
3. Injection of embryonic stem (ES) cells and/or 
embryonic germ (EG) cells, previously 
exposed to foreign DNA, into the cavity of 
blastocysts. 
4. Microinjection of genes into pronuclei of 
fertilized ova. 
5. Sperm-mediated exogenous DNA transfer 
during in vitro fertilization. 
6. Liposome-mediated DNA transfer into cells 
and embryos. 
7. Electroporation of DNA into sperm, ova or 
embryos. 
8. Biolistics. 
9. Nuclear transfer (NT) with somatic cells. 
 
2.1. DNA microinjection 
Pronuclear injection is one of the methods to 
incorporate foreign genes of interest into animals. 
The most successful and widely used method for 
producing transgenic mice is the microinjection of 
cloned DNA into the pronucleus of a fertilized ovum. 
[4]-[8]. 
The technique of DNA microinjection generally 
demands the use of micromanipulators and a 
microinjection apparatus to inject into embryos a 
solution containing recombinant DNA. Virtually any 
cloned DNA fragment can be used, albeit some 
caveats do apply. Linearized  DNA constructs are 
more promptly incorporated into the host genome. 
The presence of foreign plasmid or vector sequences 
can adversely affect expression of the integrated 
transgene. Much precaution must be taken when 
dealing large DNA constructs, such as those derived 
from bacterial or yeast artificial chromosomes, to 
avoid shearing during the process of  
microinjection. Gene constructs when microinjected, 
generally integrate randomly into the genome of the 
embryo, but typically only in a single chromosomal 
location [9]. After the gene transfer, pregnant 
recipients will follow normal gestation and deliver 
young at term. Advantges and disadvantages of DNA 
microinjection are listed in the Table 3. 
 
Table 3. Advantages and disadvantages of the DNA 
microinjection 
 
S. No Advantages of DNA microinjection 
1. A high frequency of generating transgenic 
animals from viable microinjected embryos 
transferred to recipient females. 
2. A lack of constraint on the size or type of 
DNA constructs used. 
3. The stability of the transgene as it is 
transmitted from generation to generation. 
 Disadvantages of DNA microinjection 
1. The random and potentially significant 
influence that the site of integration can exert 
on transgene expression (positional effects). 
2. The potential for undesired insertional 
mutagenesis. 
3. The time required in developing the necessary 
micromanipulation and microinjection skill 
sets. 
4. Process is inexpensive. 
 
2.2. Retrovirus-mediated gene transfer 
Retroviral methodology is also an efficient 
method to integrate genes of interest into animal 
genomes [10]. The retrovirus behaves as a naturally 
occurring delivery system to incorporate DNA into a 
number of mammalian cells [11]. Preimplantation 
embryos or oocytes [12]-[13] can be exposed in vitro 
to concentrated virus solutions or incubated over a 
single layer of virus-producing cells. Although 
embryos can be used up to midgestation, four- to 16-
cell stage embryos are primarily used for infection 
with one or more recombinant retroviruses. 
After infection, the retrovirus produces a DNA copy 
of its RNA genome using the viral enzyme reverse 
transcriptase. The DNA copy of the viral genome, or 
provirus, integrates randomly into the host cell 
genome. Embryos infected with viruses are then 
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transferred back to recipient females to complete 
gestation. The use of retroviruses produces high rates 
of gene transfer, approaching 100% efficiency.   
The virus contains the structural gene such as gag, 
pol and env which support viral particle formation. For 
safety purposes, retroviruses are frequently modified 
by removing these structural genes. However, a 
number of  retroviral lines used in transgenic animal 
experiments are ecotropic, meaning that they infect 
only the model systems (e.g. mice or rats); hence 
rodent cell lines, rather than humans, could be at risk 
of contamination if correct precautions are not taken 
[9]. Various advantages and disadvantages of using 
viral vectors in genetic engineering of agricultural 
animals were also reported [14]. Important 
disadvantages of retrovirus mediated gene transfer are 
listed in the Table 4. 
 
Table 4. Disadvantages of retrovirus-mediated gene transfer 
 
S. No Disadvantages 
1. Low copy number integration. 
2. The additional steps required to produce 
retroviruses in comparison to microinjection 
or ES cell-based techniques. 
3. General limitation on the size of the foreign 
DNA insert. 
4. A potential for undesired genetic 
recombination that might alter the replicative 
characteristics of the retrovirus. 
5. Possible interference of retroviral sequences 
on transgene expression. 
6. A high frequency of mosaicism. 
 
2.3. Embryonic stem cell technology 
Embryonic stem (ES) cell have the potential to 
form all of the cell types of the mature animal 
(muscle, nerve, skin etc) including the gamete [15]. 
Firstly the DNA of interest can be integrated into the 
cultured ES cells. The cells transfected with the gene 
of interest can be then selected. The recombinant 
selected ES ells are then incorporated into fresh 
blastocyst. In the blastocyst they are mixed with the 
cell of the inner cell mass. The blastocyst is then 
implanted into the uterus of pseudopregnant female 
and then pups were produced [16].  
The level of chimerism can be known by seeing 
the coat color of mice after birth. Because the coat 
color of the parental ES cell strain is different from 
that of the host embryo strain, mice in which both 
strains contribute to the development will display a 
mix of two coat colors. This phenomenon is termed 
chimerism. The animals showing this trait are called 
as chimeras.  
The advantage of performing genetic 
manipulations in ES cells is that verification of the 
targeted modification can be performed in vitro before 
any animal work is initiated. One of the major 
advantages of ES cell is that they are relatively 
efficient at homologous recombination in comparison 
to other animal cells. The greatest obstacle for 
generating ES-cell derived transgenic animals is due 
to the difficulties associated with the production, 
characterization and maintenance of pluripotent ES 
cell lines. 
 
2.4. Nuclear transfer 
Nuclear transfer (commonly referred to as 
„cloning‟) involves the introduction of donor nuclei 
obtained from either stem cells or differentiated adult 
cells into enucleated oocytes, thereby reprogramming 
future development. Reconstructed oocytes are then 
transferred to a surrogate mother for continuation of 
gestation. The first mammalian nuclear transfer 
experiments were reported in mice in early 1980s 
amid some controversy [17]-[18]. The use of NT 
(cloning) techniques may have the potential to 
increase the number of offspring from a single female 
into the thousands and possibly the tens of thousands 
[19]. Since the famous cloned sheep “Dolly” was 
born [20], NT technology has become another 




Biolistics is one of the methods of DNA transfer. 
Biolistics or particle bombardment is a physical 
method to transfer gene of interest. This technique 
uses accelerated microprojectiles to transfer DNA or 
other molecules into intact tissues and cells [21]. 
Initially this method was developed to transfer genes 
into plants by Sanford [22]. The main advantage of 
biolistics, compared to other transfection methods, is 
its mechanical ability to cross biological membranes 
[23]. Biolistics do not depend upon the structure and 
characteristics of target cell membranes [24] nor on 
the interaction between DNA molecules and the 
membranes. 
 
2.6. Sperm-mediated gene transfer 
Sperm mediated gene transfer is also a method 
for introducing exogenous DNA into animals for 
producing transgenics. Sperms of many species have 
been shown to bind naked DNA [25-27] as well as 
DNA-liposome complexes [28]-[29]. Generally, 
sperm are collected at ejaculation or from the 
epididymis of the testis. It is then incubated in 
fertilization medium at 37-39 ◦C for varying lengths 
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of time. The transformed sperm may be used for in 
vitro fertilization systems [25] [27] [30] or artificial 
insemination [31] [32] [27]. Successful sperm-
mediated gene transfer has been reported in the 
mouse [25] [33] [28] [30], rabbit [34]-[35], pig [36] 
[27] ,chicken, xenopus [37] and cattle [38] [27]. 
 
2.7. Liposome/DNA delivery methods 
Liposome/DNA delivery method is also used for 
transfering cloned DNA into cells and embryos. 
Liposomes are small vesicles consisting of membrane 
like lipid layers that can actually protect foreign DNA 
from digestion of proteases and DNAses [39]. 
Cationic liposomes are capable of spontaneously 
interacting with DNA molecules, giving rise to lipid-
DNA complexes [39]. Under appropriate conditions, 
exogenous DNA can be transferred into cells and a 
portion of this DNA becomes localized in the 
nucleus [39]. One-cell embryos may also be exposed 
to liposomes carrying cloned genes and potentially 
incorporate the DNA sequences into their genome.  
 
2.8. Electroporation 
Electroporation is anoher method to transfer 
cloned DNA into cells and embryos by using electric 
curent [40]-[45]. Briefly, the target cells or embryos 
are kept in a solution having the gene of interest. The 
solution and the cells are exposed to a very short 
duration of a high voltage electrical pulse. The pulse 
causes a temporary breakdown of the cell membrane. 
This technology has been utilized in attempts to 
produce transgenic animals by electroporation of 
DNA into sperm, which then carry the exogenous 
DNA to the egg at fertilization [43]. Electroporation 
of DNA into mouse ES cell lines [46] and their 
subsequent transfer into blastocysts by microinjection 
have resulted in transgenic mice [47]. This method 
has great potential either alone or in combination 
with others to efficiently transfer genes for the 
production of transgenic individuals. 
 
2.9. Intracytoplasmic sperm injection (ICSI) 
Transgenic animals can be also generated by 
intracytoplasmic sperm injection (ICSI). A passive 
technique for the production of transgenic mice 
called intracytoplasmic sperm injection-mediated 
transgenesis (ICSI-Tr) , sometimes referred to as 
metaphase II transgenesis have been developed [48]. 
In this technique mouse spermatozoa are taken. They 
are then demembranated. This is either done  by 
freeze-thawing or by treatment with a detergent such 
as TritonX-100 [49]. It is then incubated with linear, 
double stranded DNA that contains the transgene. 
The principle behind this method was that the 
exposed perinuclear theca of the sperm head would 
interact with the DNA and act as a carrier for the 
transgene. This Sperm-DNA complex is then injected 
into mature metaphase II-oocytes by ICSI, allowing 
the transgene to be transfered into the embryonic 
genome via the DNA repair mechanism [50]. One of 
the main advantages of ICSI-Tr is its higher 
efficiencies at inserting very large DNA fragments 
into the host genome, including inbred mice, as 
compared to pronuclear microinjection [51]-[53].  
 
3. Models for Transgenic 
 
Mice were used as a model to study transgenesis 
because they have well-characterized physiology, 
genetics, and short lifespan. This allows the mice for 
rapid analysis of the phenotypic changes associated 
with the transgene over their entire lifespan. A 
number of transgenic rodents are available that model 
human diseases such as sickle cell anemia [54], AIDS , 
amylotropic lateral sclerosis (ALS), also known as 
Lou Gehrigs disease [55], hepatitis B infection [55], 
ankylosingspondylitis [55] and cancer [56]. Most of 
these are produced by the highly inefficient but 
preferred pronuclear microinjection technique. The 
literature contains transgenic livestock models 
produced by pronuclear microinjection for sheep, 
pigs and rabbits [57], cows [58] and goats [59]. 
Inducible and conditional transgenic mouse models 
of schizophrenia were also reported [60]. Transgenic 
models of neurodegenerative disease were also 
studied [61]. 
 
4. Transgenic farm animals as bioreactors 
  
Transgenic mammals are used as bioreactors for 
protein production. This is very important for the 
pharmaceutical industry, because it is less expensive 
as compared to cell culture. The impetus of using 
animals as bioreactors starts from the experiments 
where transgenic mice for growth hormone (GH) 
expression demonstrated remarkable growth [62]. 
Mammary gland transgene expression allows mass 
production of large amounts of correctly processed 
proteins in a temperature-regulated fluid that may be 
collected daily in a non-invasive fashion [63]. ICSI-
mediated transgenesis with improvements offers an 
opportunity to insert large transgenes into livestock 
animals for the correct expression and processing of 
gene products. Production of large quantities of 
biological products in animal bioreactors may help to 
furnish the big demand for biomolecules that are 
presently synthesized by very expensive methods. 
035 
Journal of  Ecobiotechnology 1/1: 032-040, 2009 
5. Pharmaceutical proteins derived from 
animals 
Livestock animals have made an important 
contribution to the health of human and well-being 
throughout humankind's history. A substantial 
contribution of farm animals to human health are the 
longstanding use of bovine and porcine for yield of 
insulin, gelatin, as well as horse and sheep antibody 
against natural venoms, toxins, drugs and microbial 
peptides [64]. Gelatin being the biggest animal 
protein consumed in human health, follows with 
antibodies fragments. The chronic problem of 
animal-derived therapeutics, especially those of high 
molecular weight, is the immunogenicity induction in 
addition to their biosafety. However, the 
invertebrates and lower vertebrates donate the human 
being a several crucial emergency saving life small-
peptides or their analogs such as Refludan, Prialt, 
Exendin. Not only, but the farm animals are 
enormously using as models for novel surgical 
strategies, testing of biodegradable implants and 
sources of tissue replacements, such as skin and heart 
valves. Recently, they are being harnessing as 
bioreactor for production of biopharmaceutical 
related products through gene farming with efficiency 
far greater than any conventional microbial or cell-
culture production systems. The efficiency of the 
different animal systems to produce pharmaceutical 
proteins are described and compared to others 
including plants and micro-organisms [65]. Reports 
were also made regarding the expression of VP1 
protein in the milk of transgenic mice [66]. Several 
pharmaceutically related products derived from 
transgenic animals are listed in the Table 5. 
 
 






















6. Transgenic expression of immune- 
globulins 
 
Immunoglobulins are also produced using the 
transgenic models. The first Immunoglobulin (Ig) 
transgene expressed in a transgenic mouse encoded a 
murine κ isotype light chain [67]. Transgene 
expression was targeted to the spleen and the 
expressed protein was detected in the serum of 
transgenic animals. In 1984, a functionally rearranged 
gene encoding murine serum μ Ig was cloned and 
used to produce transgenic mice [68]. An elegant 
study was reported in which transgenic mice 
containing a human Ig-μ transgene produced a variety 
of receptor-binding variants of influenza virus 
hemagglutinin on exposure to the antigen [69]. More 
recently, transgenic cattle harboring intact un 
rearranged human Ig heavy- and λ light-chain loci 




7. Other applications and issues 
 
Some emerging applications of livestock 
transgenesis in the field of pharmacology, meat and 
dairy industry, xenotransplantation, and human 
disease modeling were analyzed. Few bioethical and 
commercial concerns raised by the transgenesis 
applications are discussed [71]. Human lysozyme 
expressed in the mammary gland of transgenic dairy 
goats can inhibit the growth of bacteria that cause 
mastitis and the cold-spoilage of milk [72]. 
Recombinant porcine lactoferrin expressed in the 
milk of transgenic mice enhances offspring growth 
performance was also reported [73]. A method for 
rapid generation of transgenic animals to evaluate 
testis genes during sexual maturation was studied [74]. 
Endocrine effects of growth hormone over 
expression in transgenic coho salmon were also 
reported [75]. Cataracts in transgenic mice caused by 
a human papillomavirus type 18 E7 oncogene driven 
by KRT1-14 were also studied [76]. It was reported 
that valproate ameliorates the survival and the motor 
performance in a transgenic mouse model of 




Transgenic technologies generated great 
excitement in the scientific community and the 
pharmaceutical industry. These technologies solved a 
number of biological problems. There are a number 
of new and developing technologies that will have a 
profound impact on the genetic improvement of 
livestock. The rate at which these technologies are 
incorporated into production schemes will determine 
the speed at which we will be able to achieve our goal 
of more efficiently producing livestock, which meets 
consumer and market demand. It is the requirement 
of the present time to have more advanced 
technologies for integrating the gene of interest 
without damaging its biological property so to 
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